FMR LLC 13D/13G Filings for Acceleron Pharma Inc. (XLRN)

FMR LLC 13D and 13G filings for Acceleron Pharma Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-11-10
12:24 pm
Sale
2021-11-0913GACCELERON PHARMA INC
XLRN
FMR LLC493,493
0.807%
-4,184,920decrease
(-89.45%)
Filing